在阿尔茨海默氏症疾病中,血清能调节
Lyudmila P Dolgacheva1, Valery P Zinchenko1, Alexander D Nadeev1
1Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", Institute of Cell Biophysics of the Russian Academy of Sciences, Pushchino 142290, Russia.
International journal of molecular sciences
|June 13, 2025
概括
血清素 (5-HT) 功能障碍通过影响大脑发育和线粒体健康,导致阿尔茨海默病 (AD). 准5-HT系统为AD预防和治疗提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 病理学 病理学 病理学
背景情况:
- 血清素 (5-HT) 调节血管和血管生成,其系统与阿尔茨海默氏症 (AD) 病原发生有关.
- 5-HT系统的功能障碍与AD发展,抑郁和压力有关,在5-HT受体中具有潜在的治疗点.
- 循环节律障碍通过损害粉样β (Aβ) 斑块清除和调节疾病进展而加剧AD.
研究的目的:
- 审查血清素 (5-HT) 系统在阿尔茨海默病 (AD) 病理学的参与.
- 探索5-HT在大脑发育,神经元可塑性和神经保护中的作用.
- 讨论针对AD预防和治疗的5-HT系统的治疗策略.
主要方法:
- 关于血清素,阿尔茨海默氏症和相关因素的研究文献综述.
- 分析5-HT对Aβ斑块清除,昼夜节律和线粒体功能的影响.
- 检查5-HT的神经发育和神经再生作用.
主要成果:
- 血清素 (5-HT) 系统损伤有助于AD;5-HT受体亚型是潜在的治疗点.
- 粉样β oligomers (AβO) 与线粒体的相互作用会触发AD神经退行.
- 5-HT改善了线粒体质量,并有助于在受伤或压力后恢复大脑区域,与AD相关.
结论:
- 血清素 (5-HT) 系统在大脑发育,可塑性和神经保护方面发挥着关键作用,影响阿尔茨海默病的进展.
- 准5-HT受体和促进健康的生活方式可能为AD预防和治疗提供有希望的途径.
- 恢复5-HT功能可以改善线粒体健康,帮助从神经损伤中恢复,抵消AD相关的神经退行.
相关概念视频
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Role of Neurotransmitters in Memory
492
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
492
G-protein Coupled Receptors
117.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.3K


